News for GDRX Stock

GoodRx to Participate in the 44th Annual J.P. Morgan Healthcare Conference GoodRx Launches New $39 Per Month Weight Loss Telemedicine Subscription, Unveils Industry-Leading Introductory Cash Price of $199 Per Month for Ozempic® and Wegovy® GoodRx Reports Third Quarter 2025 Results GoodRx Launches New Hair Loss Subscription for Men to Simplify Access to Affordable Treatment GoodRx Announces Date for Third Quarter 2025 Earnings Release and Conference Call GoodRx Expands Affordable Access to Repatha® with Nearly 60% Savings GoodRx Launches Brand Medication Savings Program at National Retail Pharmacy GoodRx Saddles Up With “The Savings Wrangler,” a Bold New Brand Campaign to Tame the Wild West of Prescription Pricing GoodRx Announces Collaboration with Novo Nordisk to Expand Access to Ozempic® and Wegovy® for $499-Per-Month GoodRx Reports Second Quarter 2025 Results GoodRx Appoints Amazon Pharmacy Veteran Laura Jensen as President of Pharma Solutions GoodRx Announces Date for Second Quarter 2025 Earnings Release and Conference Call GoodRx Launches New Erectile Dysfunction Subscription Service to Simplify Access and Eliminate Treatment Barriers GoodRx Open Sources Lifecycle to Support Innovation in Software Development Velocity and Developer Productivity GoodRx to Launch Direct Contracting for Independent Community Pharmacies GoodRx Reports First Quarter 2025 Results GoodRx Announces Date for First Quarter 2025 Earnings Release and Conference Call GoodRx Introduces New E-commerce Experience for Retail Pharmacies GoodRx Appoints Aaron Crittenden as President of Rx Marketplace and Scott Pope, PharmD, as Chief Pharmacy Officer and Head of Clinical Engagement GoodRx Report Reveals Striking Gender Divide in Prescription Medication Spending GoodRx Reports Fourth Quarter and Full Year 2024 Results GoodRx Achieves HITRUST i1 Certification to Manage Data Protection and Mitigate Cybersecurity Threats GoodRx Appoints Christopher A. McGinnis as Chief Financial Officer GoodRx Announces Date for Fourth Quarter and Full Year 2024 Earnings Release and Conference Call Scott Wagner Joins GoodRx Board of Directors GoodRx Offering Free Telehealth Appointments to Los Angeles Residents Affected by Wildfires GoodRx Unleashes “GoodRx for Pets,” Simplifying Access and Reducing Costs for Pet Medications WM Technology, Inc. Names Sarah Griffis Chief Technology Officer GoodRx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference GoodRx Report Shows Millions at Risk as Endocrinologist Shortages Hit Nearly 70% of U.S. Counties GoodRx Appoints Healthcare Industry Veteran, Wendy Barnes, as New Chief Executive Officer GoodRx Reveals Americans Overspent on Weight Loss Medications by $200 Million This Year, Fills Still Surged Harrow Launches Access and Affordability Program with Price Reductions for Branded Products GoodRx Reports Third Quarter 2024 Results GoodRx to Participate in Upcoming Investor Conferences GoodRx Unveils New E-commerce Platform, Launches with Opill® GoodRx Announces Exclusive Low Cash Price for QSYMIA®, the Leading Branded Once-Daily Oral Weight Management Medication for Adults Ronald E. Bruehlman Joins GoodRx Board of Directors GoodRx Announces New Affordability Programs for Menopause Hormone Therapies GoodRx Partnering with Retail Pharmacies to Deliver Pay-Over-Time Option Directly to Consumers GoodRx Announces Date for Third Quarter 2024 Earnings Release and Conference Call GoodRx Announces Lowest Discounted Cash Price at Retail Pharmacy Locations for neffy® (epinephrine nasal spray) GoodRx to Participate in Upcoming Investor Conferences GoodRx Reports Second Quarter 2024 Results Boehringer Ingelheim and GoodRx announce exclusive patient affordability initiative for Adalimumab-adbm injection, Boehringer's biosimilar to Humira® GoodRx Announces Date for Second Quarter 2024 Earnings Release and Conference Call Ian T. Clark Joins GoodRx Board of Directors GoodRx Launches New “Prescription Cost Tracker” to Spotlight Key Factors Driving Out-of-Pocket Medication Costs in the U.S. Simon Patterson Joins GoodRx Board of Directors GoodRx Named One of the 2024 TIME100 Most Influential Companies GoodRx Offers Discounts of Up to 43% On Fertility Treatments GoodRx and Kroger Sign Direct Contracting Agreement GoodRx Reports First Quarter 2024 Results GoodRx Announces Date for 2024 Investor Day GoodRx Announces Date for First Quarter 2024 Earnings Release and Conference Call GoodRx Interim CEO Extends Commitment to Company GoodRx Reports Fourth Quarter and Full Year 2023 Results GoodRx to Participate in Upcoming Investor Conferences GoodRx Announces Date for Fourth Quarter and Full Year 2023 Earnings Release and Conference Call GoodRx Announces Proposed Refinancing of First Lien Credit Facilities The GoodRx Effect: Delivering a Transformative Impact on the U.S. Healthcare System through Prescription Savings GoodRx Announces Preliminary Fourth Quarter and Full Year 2023 Results and Early Expectations for First Quarter and Full Year 2024 GoodRx Appoints Kelly J. Kennedy to Board of Directors GoodRx to Participate in the 42nd Annual J.P. Morgan Healthcare Conference Amino Health Announces John Asalone as New CEO; David Vivero Assumes Role of Chairman in CEO Succession Established Executive and Milwaukee Business Leader Jim Emling Joins VBA as Executive Chair of the Board of Directors GoodRx to Participate in the Evercore ISI HealthCONx Conference GoodRx Reports Third Quarter 2023 Results GoodRx Announces New Way for Consumers to Access Sanofi’s Lantus for $35 at Over 70,000 Pharmacies Nationwide GoodRx Announces Date for Third Quarter 2023 Earnings Release and Conference Call GoodRx and Navitus Health Solutions Announce Savings Connect Program to Deliver Lower Prescription Prices for Navitus Members GoodRx Announces Significant Savings on Antivirals, Medications and Vaccines for Cold & Flu Season GoodRx and MedImpact Announce Program to Ensure Seamless Access to Affordable Prescriptions GoodRx Now Offers 40% More Savings on Nearly 200 Medications at Walgreens GoodRx to Present at the Morgan Stanley Global Healthcare Conference GoodRx Launches Real-Time Benefit Check In Provider Mode To Offer Comprehensive Cost Information At The Point of Prescribing GoodRx Reports Second Quarter 2023 Results GoodRx Unveils Medicine Cabinet, A Better Way To Manage All Of Your Prescriptions GoodRx Announces Date for Second Quarter 2023 Earnings Release and Conference Call CVS Caremark and GoodRx to launch Caremark® Cost Saver™ to help lower out-of-pocket drug costs for CVS Caremark clients' members GoodRx Appoints Dorothy Gemmell as Chief Commercial Officer GoodRx to Present at the Jefferies Healthcare Conference GoodRx Reports First Quarter 2023 Results GoodRx to Present at the BofA Securities 2023 Health Care Conference GoodRx Expands Executive Team With New Interim CEO GoodRx Announces Date for First Quarter 2023 Earnings Release and Conference Call GoodRx Reports Fourth Quarter and Full Year 2022 Results GoodRx to Present at the Cowen 43rd Annual Health Care Conference GoodRx Announces Date for Fourth Quarter and Full Year 2022 Earnings Release and Conference Call GoodRx to Present at the 41st Annual J.P. Morgan Healthcare Conference GoodRx Reports Third Quarter 2022 Results New Report from GoodRx Shows Positive Impact of Giving Pharmacists the Power to Prescribe GoodRx to Present at Upcoming Investor Conferences GoodRx and Biogen Collaborate to Help Enhance Enrollment Experience for Providers Who Have Chosen to Start Multiple Sclerosis Patients on VUMERITY® GoodRx Announces Provider Mode, An Innovative Experience Built Specifically for Healthcare Providers GoodRx Announces Date for Third Quarter 2022 Earnings Release and Conference Call GoodRx Offers Free Telehealth Appointments to Florida Residents Affected by Hurricane Ian GoodRx to Present at the Goldman Sachs Communacopia + Technology Conference GoodRx Releases Second Quarter 2022 Financial Results GoodRx Offers Free Telehealth Appointments to Kentucky Residents Affected by Flooding GoodRx to Present Virtually at the Bank of America SMID Cap Ideas Conference GoodRx Announces Date for Second Quarter 2022 Earnings Release and Conference Call GoodRx and RxVantage Announce Strategic Relationship to Streamline Communications Between Providers and Manufacturers GoodRx Releases First Quarter 2022 Financial Results GoodRx Appoints Raj Beri as Chief Operating Officer, Mark Hull as Chief Product Officer and Vina Leite as Chief People Officer GoodRx to Present at the RBC Capital Markets 2022 Global Healthcare Conference Relay Robotics Secures $10 Million Financing GoodRx Teams Up with AssistRx to Increase Provider Awareness of Simplified Specialty Medication and Treatment Initiation TherapeuticsMD Completes the Divestiture of vitaCare Prescription Services to GoodRx in a Cash Transaction Valued at $150 Million GoodRx Closes Acquisition of vitaCare, A Tech-Enabled Pharmacy Services Platform GoodRx Announces Date for First Quarter 2022 Earnings Release and Conference Call TherapeuticsMD Enters Into a Definitive Agreement to Divest vitaCare to GoodRx GoodRx Agrees to Acquire vitaCare, A Tech-Enabled Pharmacy Services Platform GoodRx Announces $250 Million Share Repurchase Program GoodRx Releases Fourth Quarter and Full Year 2021 Financial Results GoodRx to Present at Upcoming Investor Conferences GoodRx Announces Date for Fourth Quarter and Full Year 2021 Earnings Release and Conference Call GoodRx to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference GoodRx to Present at Upcoming Investor Conferences GoodRx Releases New Report Examining the State of Telehealth GoodRx Releases Third Quarter 2021 Financial Results GoodRx Announces Date for Third Quarter 2021 Earnings Release and Conference Call GoodRx to Present at the Morgan Stanley Annual Spark Conference Fetch Rewards Names GoodRx Exclusive Prescription Savings Provider GoodRx Launches GoodRx Health, A Next-Generation Online Health Resource GoodRx to Host Educational Webinar CORRECTING and REPLACING New Internal Survey Shows Strength of Relationship Between GoodRx and Healthcare Providers New Internal Survey Shows Strength of Relationship Between GoodRx and Healthcare Providers GoodRx to Present Virtually at Upcoming Investor Conferences GoodRx Releases Second Quarter 2021 Financial Results CORRECTING and REPLACING - GoodRx and Boehringer Ingelheim Announce Joint Effort to Deliver Affordability Solutions to Patients GoodRx and Boehringer Ingelheim Announce Joint Effort to Deliver Affordability Solutions to Patients GoodRx Announces Agreement with Surescripts to Provide Real-Time Drug Discount Pricing in Electronic Health Records GoodRx Savings Increase Pharmacy Visits and Customer Loyalty For Retailers GoodRx Announces Date for Second Quarter 2021 Earnings Release and Conference Call GoodRx and DoorDash Partner to Provide Dashers Nationwide with Access to GoodRx Gold The GoodRx Effect: How GoodRx is Changing the Economics of Healthcare GoodRx Releases First Quarter 2021 Financial Results GoodRx to Present Virtually at Upcoming Investor Conferences GoodRx Announces Streamlined Access to Sanofi Savings Programs GoodRx Expands Manufacturer Solutions Offering with Acquisition of HealthiNation GoodRx Announces Date for First Quarter 2021 Earnings Release and Conference Call GoodRx Offers Largest Appointment Tracker for COVID-19 Vaccines GoodRx Releases Fourth Quarter and Full Year 2020 Financial Results GoodRx Launches GoodRx Helps, a $40+ Million Charitable Initiative to Help Improve Healthcare for Americans Who Need It Most GoodRx Announces Date for Fourth Quarter and Full Year 2020 Earnings Release and Conference Call GoodRx to Present Virtually at Upcoming Investor Conferences GoodRx Celebrated for Culture and Leadership With Four Comparably Awards GoodRx Adds Telehealth and Mail Order to GoodRx Gold Savings Program GoodRx Releases Third Quarter 2020 Financial Results GoodRx to Present Virtually at Upcoming Investor Conferences GoodRx Announces Date for Third Quarter 2020 Earnings Release and Conference Call GoodRx and Kroger Health Agree to Multiyear Renewal of Kroger Rx Savings Club Relationship